3.連結財務諸表及び主な注記
(1)連結貸借対照表
| | (単位:百万円) |
| 前連結会計年度 (2024年11月30日) | 当連結会計年度 (2025年11月30日) |
資産の部 | | |
流動資産 | | |
現金及び預金 | 6,101 | 10,190 |
受取手形、売掛金及び契約資産 | 16,703 | 18,858 |
電子記録債権 | 4,643 | 4,066 |
商品及び製品 | 6,136 | 8,041 |
仕掛品 | 1,866 | 1,650 |
原材料及び貯蔵品 | 2,403 | 2,514 |
その他 | 1,295 | 2,038 |
貸倒引当金 | △8 | △21 |
流動資産合計 | 39,141 | 47,339 |
固定資産 | | |
有形固定資産 | | |
建物及び構築物 | 10,560 | 10,910 |
減価償却累計額 | △6,723 | △7,024 |
建物及び構築物(純額) | 3,837 | 3,885 |
機械装置及び運搬具 | 10,994 | 11,937 |
減価償却累計額 | △9,045 | △9,446 |
機械装置及び運搬具(純額) | 1,949 | 2,491 |
工具、器具及び備品 | 4,454 | 5,088 |
減価償却累計額 | △3,166 | △3,601 |
工具、器具及び備品(純額) | 1,288 | 1,486 |
土地 | 2,447 | 2,614 |
リース資産 | 355 | 384 |
減価償却累計額 | △224 | △191 |
リース資産(純額) | 130 | 192 |
建設仮勘定 | 2,266 | 2,620 |
有形固定資産合計 | 11,920 | 13,291 |
無形固定資産 | | |
ソフトウエア | 715 | 680 |
のれん | 3,752 | 4,755 |
技術資産 | 439 | 404 |
顧客関連資産 | 1,617 | 1,412 |
その他 | 370 | 385 |
無形固定資産合計 | 6,893 | 7,638 |
投資その他の資産 | | |
投資有価証券 | 4,137 | 4,291 |
退職給付に係る資産 | 1,071 | 1,539 |
繰延税金資産 | 960 | 517 |
その他 | 494 | 848 |
貸倒引当金 | △23 | △24 |
投資その他の資産合計 | 6,639 | 7,172 |
固定資産合計 | 25,453 | 28,102 |
繰延資産 | | |
創立費 | 0 | 0 |
繰延資産合計 | 0 | 0 |
資産合計 | 64,595 | 75,441 |
| | (単位:百万円) |
| 前連結会計年度 (2024年11月30日) | 当連結会計年度 (2025年11月30日) |
負債の部 | | |
流動負債 | | |
支払手形及び買掛金 | 9,272 | 9,551 |
電子記録債務 | 4,339 | 5,056 |
短期借入金 | 11,390 | 16,195 |
未払費用 | 3,166 | 3,493 |
未払法人税等 | 732 | 853 |
賞与引当金 | 684 | 815 |
製品保証引当金 | 58 | 23 |
災害損失引当金 | 14 | - |
その他 | 2,243 | 2,084 |
流動負債合計 | 31,903 | 38,074 |
固定負債 | | |
長期借入金 | 3,445 | 6,250 |
リース債務 | 86 | 141 |
繰延税金負債 | 909 | 309 |
株式報酬引当金 | 105 | 137 |
退職給付に係る負債 | 2,403 | 2,306 |
その他 | 439 | 823 |
固定負債合計 | 7,389 | 9,969 |
負債合計 | 39,293 | 48,043 |
純資産の部 | | |
株主資本 | | |
資本金 | 4,605 | 4,629 |
資本剰余金 | 6,320 | 6,344 |
利益剰余金 | 12,229 | 13,680 |
自己株式 | △255 | △255 |
株主資本合計 | 22,900 | 24,399 |
その他の包括利益累計額 | | |
その他有価証券評価差額金 | 1,388 | 1,438 |
繰延ヘッジ損益 | △2 | 0 |
為替換算調整勘定 | 319 | 458 |
退職給付に係る調整累計額 | 560 | 803 |
その他の包括利益累計額合計 | 2,265 | 2,699 |
非支配株主持分 | 136 | 298 |
純資産合計 | 25,302 | 27,397 |
負債純資産合計 | 64,595 | 75,441 |
E0258580950アステナホールディングス株式会社Astena Holdings Co., Ltd.通期第1号参考様式 [日本基準](連結)Japan GAAPtrueCTECTE2024-12-012025-11-30FY2025-11-302023-12-012024-11-302024-11-301falsefalsefalse809502023-12-012024-11-30jppfs_cor:CapitalStockMember809502023-12-012024-11-30jppfs_cor:CapitalSurplusMember809502023-12-012024-11-30jppfs_cor:ShareholdersEquityMember809502023-12-012024-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502023-12-012024-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502023-12-012024-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502023-12-012024-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502023-12-012024-11-30jppfs_cor:RetainedEarningsMember809502024-11-30jppfs_cor:CapitalStockMember809502024-11-30jppfs_cor:CapitalSurplusMember809502024-11-30jppfs_cor:RetainedEarningsMember809502024-11-30jppfs_cor:TreasuryStockMember809502024-11-30jppfs_cor:ShareholdersEquityMember809502024-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502024-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502024-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502025-11-30jppfs_cor:CapitalSurplusMember809502025-11-30jppfs_cor:RetainedEarningsMember809502025-11-30jppfs_cor:TreasuryStockMember809502025-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502025-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502025-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502025-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502024-12-012025-11-30jppfs_cor:CapitalSurplusMember809502024-12-012025-11-30jppfs_cor:RetainedEarningsMember809502024-12-012025-11-30jppfs_cor:TreasuryStockMember809502024-12-012025-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502024-12-012025-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502024-12-012025-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502024-12-012025-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502025-11-30jppfs_cor:ShareholdersEquityMember809502025-11-30jppfs_cor:CapitalStockMember809502023-12-012024-11-30jppfs_cor:TreasuryStockMember809502023-11-30jppfs_cor:CapitalStockMember809502023-11-30jppfs_cor:CapitalSurplusMember809502023-11-30jppfs_cor:RetainedEarningsMember809502023-11-30jppfs_cor:TreasuryStockMember809502023-11-30jppfs_cor:ShareholdersEquityMember809502023-11-30jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember809502023-11-30jppfs_cor:DeferredGainsOrLossesOnHedgesMember809502023-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502023-11-30jppfs_cor:ValuationAndTranslationAdjustmentsMember809502024-12-012025-11-30jppfs_cor:ShareholdersEquityMember809502024-11-30jppfs_cor:ForeignCurrencyTranslationAdjustmentMember809502025-11-30jppfs_cor:NonControllingInterestsMember809502024-12-012025-11-30jppfs_cor:NonControllingInterestsMember809502024-11-30jppfs_cor:NonControllingInterestsMember809502023-12-012024-11-30jppfs_cor:NonControllingInterestsMember809502023-11-30jppfs_cor:NonControllingInterestsMember809502025-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502024-12-012025-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502024-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502023-12-012024-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502023-11-30jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember809502023-12-012024-11-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember809502023-12-012024-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502025-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502025-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502025-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502025-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502024-12-012025-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502024-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:FineChemicalsReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:HealthAndBeautyCareFoodReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:MedicalReportableSegmentsMember809502023-12-012024-11-30tse-acedjpfr-80950:IndustrialChemicalsReportableSegmentsMember809502024-12-012025-11-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember809502024-12-012025-11-30jpcrp_cor:ReconcilingItemsMember809502023-12-012024-11-30jpcrp_cor:TotalOfReportableSegmentsAndOthersMember809502023-12-012024-11-30jpcrp_cor:ReconcilingItemsMember809502023-12-012024-11-30jpcrp_cor:ReportableSegmentsMember809502024-12-012025-11-30jppfs_cor:CapitalStockMember809502026-01-13809502025-11-30809502024-12-012025-11-30809502024-11-30809502023-12-012024-11-30809502023-11-30809502025-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502024-12-012025-11-30jpcrp_cor:ReportableSegmentsMember809502024-12-012025-11-30jpcrp_cor:OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember809502024-12-012025-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502024-11-30jpcrp_cor:UnallocatedAmountsAndEliminationMember809502025-11-30jpcrp_cor:OtherReportableSegmentsMember809502024-12-012025-11-30jpcrp_cor:OtherReportableSegmentsMember809502024-11-30jpcrp_cor:OtherReportableSegmentsMember809502023-12-012024-11-30jpcrp_cor:OtherReportableSegmentsMemberxbrli:pureiso4217:JPY